Your browser version may not work well with NCBI's Web applications. More information here...
1: Clin Med. 2008 Feb;8(1):42-8.Click here to read Links

Recent developments in acute coronary syndromes.

Iqbal MB, Westwood MA, Swanton RH.

The Heart Hospital, University College London Hospitals NHS Trust. biqbal@excite.com

Coronary artery disease is the leading cause of death in the UK with a high clinical, social and economic burden. The management of acute coronary syndromes is rapidly evolving and clinicians are constantly challenged with incorporating new clinical pathways and guidelines into their practices. It is important for clinicians to have a sound working knowledge of acute coronary syndromes, and be updated on the emerging evidence to guide therapy and improve outcomes in these patients.

PMID: 18335668 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Ticlopidine (Ticlid® )

    Ticlopidine is used to reduce the risk of stroke. It works by preventing excessive blood clotting.

  • Clopidogrel (Plavix, Ticlid, Persantine, ...)

    How do antiplatelet agents compare in acute coronary syndromes?

  • Clopidogrel (Plavix® )

    Clopidogrel is used to prevent strokes and heart attacks in patients at risk for these problems. Clopidogrel is in a class of medications called antiplatelet drugs. It works by helping to prevent harmful blood clots that...

  • Source: AHFS Consumer Medication Information